Neu-REFIX Beta Glucan Gets Rare Pediatric Disease and ODD from US FDA for Treatment of Duchenne Muscular Dystrophy

Neu REFIX Beta glucan, made in Japan, has received both Rare Pediatric Disease Designation (RPDD) and Orphan Drug Designation (ODD) from the U.S. Food and Drug Administration (US FDA) for [...]